Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03473912
What this trial is testing

Meir Medical Center Rheumatologic Biobank

Who this might be right for
Rheumatoid ArthritisLupus Erythematosus, SystemicSystemic Sclerosis+2 more
Meir Medical Center 500
Not applicableLooking for participantsNCT06503224
What this trial is testing

An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China 18
Testing effectiveness (Phase 2)Looking for participantsNCT06058091
What this trial is testing

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Jiangsu Renocell Biotech Company 81
Not applicableLooking for participantsNCT07402226
What this trial is testing

Systemic Sclerosis DIet for GastrointESTinal Symptoms

Who this might be right for
Systemic Sclerosis (SSc)
University of Michigan 60
Not applicableUnknownNCT05105217
What this trial is testing

Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients

Who this might be right for
Systemic Lupus Erythematosus
Assiut University 85
Testing effectiveness (Phase 2)Study completedNCT00278525
What this trial is testing

Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma

Who this might be right for
SYSTEMIC SCLERODERMA
Northwestern University 19
Not applicableStudy completedNCT05622578
What this trial is testing

Phenotyping of Chronic Pain in Diffused Systemic Scleroderma

Who this might be right for
Scleroderma, SystemicScleroderma, Diffuse
Assistance Publique - Hôpitaux de Paris 100
Not applicableUnknownNCT04303208
What this trial is testing

Sirtuin 3 and Sirtuin 7 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Assiut University 80
Post-approval studies (Phase 4)UnknownNCT01002508
What this trial is testing

Influenza Vaccination in Patients With Scleroderma

Who this might be right for
Influenza Vaccine in Scleroderma
Tel-Aviv Sourasky Medical Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT06189495
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicableUnknownNCT02206672
What this trial is testing

EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS

Who this might be right for
Systemic Sclerosis
Assistance Publique Hopitaux De Marseille 15
Not applicableStudy completedNCT02887495
What this trial is testing

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

Who this might be right for
Scleroderma
George Washington University 600
Testing effectiveness (Phase 2)Study completedNCT02663895
What this trial is testing

Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisCalcinosis
Stanford University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Not applicableLooking for participantsNCT07348263
What this trial is testing

EFESO: Study on Juvenile Onset Eosinophilic Fasciitis

Who this might be right for
Eosinophilic Fasciitis
Meyer Children's Hospital IRCCS 20
Early research (Phase 1)Looking for participantsNCT06249438
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3 more
RenJi Hospital 30
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Testing effectiveness (Phase 2)Study completedNCT00043706
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis

Who this might be right for
Systemic SclerosisScleroderma
Genzyme, a Sanofi Company
Not applicableStudy completedNCT01233999
What this trial is testing

Botulinum Toxin in the Treatment of Raynaud's

Who this might be right for
Raynaud's Syndrome
Emory University 10
Testing effectiveness (Phase 2)UnknownNCT04118699
What this trial is testing

Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

Who this might be right for
Chronic Intestinal Pseudo-obstruction
Yokohama City University 12
Next Page
30